Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 78.60
+1.50 (1.95%)
Jun 18, 2025, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 127.34 billion as of June 18, 2025. Its market cap has increased by 111.51% in one year.
Market Cap
127.34B
Enterprise Value
121.96B
Revenue
10.03B
Ranking
n/a
PE Ratio
n/a
Stock Price
78.60
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 127.34B, an increase of 586.86%. That is a compound annual growth rate of 33.71%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 264.50B |
| Hansoh Pharmaceutical Group Company | 174.21B |
| JD Health International | 134.72B |
| WuXi Biologics | 107.82B |
| CSPC Pharmaceutical Group | 100.00B |
| Sino Biopharmaceutical | 89.42B |
| Akeso | 84.42B |
| Alibaba Health Information Technology | 75.89B |